Insights into the antiosteoporotic mechanism of the soy‐derived isoflavone genistein: Modulation of the Wnt/beta‐catenin signaling

The Nutraceutical Genistein-Lycopene Combination Improves Bone Damage Induced by Glucocorticoids by Stimulating the Osteoblast Formation Process

(2022) Federica Mannino et al.   Nutrients

Osteoporosis

(2019) Juliet E Compston et al.   LANCET

Aberrant activation of Wnt signaling pathway altered osteocyte mineralization

(2019) Yinghong Zhou et al.   BONE

Activation of the EPOR-β common receptor complex by cibinetide ameliorates impaired wound healing in mice with genetic diabetes

(2018) Alessandra Bitto et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Effect of Human Wnt10b Transgene Overexpression on Peri-Implant Osteogenesis in Ovariectomized Rats

(2018) Hanghang Liu et al.   HUMAN GENE THERAPY

The underlying pathophysiology and therapeutic approaches for osteoporosis

(2018) Harshika Awasthi et al.   MEDICINAL RESEARCH REVIEWS

Estrogen therapy for osteoporosis in the modern era

(2018) V. A. Levin et al.   OSTEOPOROSIS INTERNATIONAL

Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity

(2018) Antonio Micali et al.   Oxidative Medicine and Cellular Longevity

The bone remodelling cycle

(2018) JS Kenkre et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Stress, Glucocorticoids and Bone: A Review From Mammals and Fish

(2018) Paula Suarez-Bregua et al.   Frontiers in Endocrinology

Genistein and menaquinone-4 treatment-induced alterations in the expression of mRNAs and their products are beneficial to osteoblastic MC3T3-E1 cell functions

(2017) Midori Katsuyama et al.   Molecular Medicine Reports

Management of Postmenopausal Osteoporosis

(2015) Panagiota Andreopoulou et al.   Annual Review of Medicine

Immunology of Osteoporosis: A Mini-Review

(2015) Peter Pietschmann et al.   GERONTOLOGY

Regulation of bone metabolism by Wnt signals

(2015) Yasuhiro Kobayashi et al.   JOURNAL OF BIOCHEMISTRY

Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone

(2015) Xiaolin Tu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Role of Wnt Signaling and Sclerostin in the Pathogenesis of Glucocorticoid-Induced Osteoporosis

(2014) Núria Guañabens et al.   Current Osteoporosis Reports

Genistein induces oestrogen receptor-α gene expression in osteoblasts through the activation of mitogen-activated protein kinases/NF-κB/activator protein-1 and promotes cell mineralisation

(2013) Mei-Hsiu Liao et al.   BRITISH JOURNAL OF NUTRITION

An overview of the regulation of bone remodelling at the cellular level

(2012) Jasreen Kular et al.   CLINICAL BIOCHEMISTRY

Inhibition of Wnt/β-catenin signaling by dexamethasone promotes adipocyte differentiation in mesenchymal progenitor cells, ROB-C26

(2012) Masako Naito et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling

(2012) Lei-Guo Ming et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation

(2010) Joseph S Butler et al.   BMC MUSCULOSKELETAL DISORDERS

Genistein aglycone improves skin repair in an incisional model of wound healing: a comparison with raloxifene and oestradiol in ovariectomized rats

(2010) H Marini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Genistein Aglycone: A Dual Mode of Action Anti-Osteoporotic Soy Isoflavone Rebalancing Bone Turnover Towards Bone Formation

(2010) A. Bitto et al.   CURRENT MEDICINAL CHEMISTRY

Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells

(2010) Jennifer R Stevens et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Developmentally regulated inhibition of cell cycle progression by glucocorticoids through repression of cyclin a transcription in primary osteoblast cultures

(2010) Yankel Gabet et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate

(2009) A Bitto et al.   BRITISH JOURNAL OF PHARMACOLOGY

Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats

(2009) Alessandra Bitto et al.   JOURNAL OF ENDOCRINOLOGY

Osteoclast–osteoblast communication

(2008) Koichi Matsuo et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Osteocytes, mechanosensing and Wnt signaling

(2008) Lynda F. Bonewald et al.   BONE

Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol

(2008) A Bitto et al.   BRITISH JOURNAL OF PHARMACOLOGY

OPG and sRANKL Serum Concentrations in Osteopenic, Postmenopausal Women After 2-Year Genistein Administration

(2008) Herbert Marini et al.   JOURNAL OF BONE AND MINERAL RESEARCH